These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 8279838
1. ["State of the art" of chemotherapy for lung cancer]. Fukuoka M. Gan To Kagaku Ryoho; 1993 Dec; 20(16):2429-36. PubMed ID: 8279838 [Abstract] [Full Text] [Related]
2. [Recent progress in chemotherapy for advanced lung cancer]. Negoro S, Fukuoka M. Gan To Kagaku Ryoho; 1995 Mar; 22(4):451-60. PubMed ID: 7887637 [Abstract] [Full Text] [Related]
3. [The recent progress in chemoradiotherapy of lung cancer]. Ogawara M, Kawahara M, Furuse K. Gan To Kagaku Ryoho; 1997 Nov; 24(14):2058-64. PubMed ID: 9388514 [Abstract] [Full Text] [Related]
4. [Phase III studies of combined chemotherapy and radiation in locally advanced non-small-cell lung cancer and limited small-cell lung cancer]. Kawahara M. Gan To Kagaku Ryoho; 1995 Feb; 22(3):335-40. PubMed ID: 7880104 [Abstract] [Full Text] [Related]
5. [Evidence based chemotherapy for lung cancer]. Watanabe H, Saijo N. Gan To Kagaku Ryoho; 2000 Jan; 27(1):30-43. PubMed ID: 10660731 [Abstract] [Full Text] [Related]
6. [Treatment of lung cancer--state of the art in 2000]. Nakanishi Y, Inoue K, Hara N. Gan To Kagaku Ryoho; 2000 Jul; 27(8):1247-52. PubMed ID: 10945023 [Abstract] [Full Text] [Related]
7. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group. Segawa Y, Ueoka H, Kiura K, Kamei H, Tabata M, Sakae K, Hiraki Y, Kawahara S, Eguchi K, Hiraki S, Harada M. Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975 [Abstract] [Full Text] [Related]
8. Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Bunn PA. Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-153-S12-162. PubMed ID: 9331142 [Abstract] [Full Text] [Related]
9. Patterns of care survey (PCS) in lung cancer: how well does current U.S. practice with chemotherapy in the non-metastatic setting follow the literature? Langer CJ, Moughan J, Movsas B, Komaki R, Ettinger D, Owen J, Wilson JF. Lung Cancer; 2005 Apr; 48(1):93-102. PubMed ID: 15777975 [Abstract] [Full Text] [Related]
10. [Combined radiotherapy and chemotherapy modalities in the treatment of lung cancer]. Furuse K, Kawahara M, Arai R, Kodama N, Yamamoto M, Kubota K, Ogawara M, Nakai R. Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1628-33. PubMed ID: 2837998 [Abstract] [Full Text] [Related]
11. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer]. Bozóky G, Ruby E, Góhér I, Gábor G, Mohos A, Lengyel M. Orv Hetil; 2005 Jul 03; 146(27):1433-8. PubMed ID: 16089103 [Abstract] [Full Text] [Related]
12. Combined modality therapy of lung cancer. Livingston RB. Clin Cancer Res; 1997 Dec 03; 3(12 Pt 2):2638-47. PubMed ID: 10068267 [Abstract] [Full Text] [Related]
13. Combination of radiotherapy and chemotherapy in locally advanced NSCLC. Kepka L, Sprawka A, Casas F, Abdel-Wahab S, Agarwal JP, Jeremic B. Expert Rev Anticancer Ther; 2009 Oct 03; 9(10):1389-403. PubMed ID: 19827998 [Abstract] [Full Text] [Related]
14. Long-term results of a phase III trial comparing once-daily radiotherapy with twice-daily radiotherapy in limited-stage small-cell lung cancer. Schild SE, Bonner JA, Shanahan TG, Brooks BJ, Marks RS, Geyer SM, Hillman SL, Farr GH, Tazelaar HD, Krook JE, Geoffroy FJ, Salim M, Arusell RM, Mailliard JA, Schaefer PL, Jett JR. Int J Radiat Oncol Biol Phys; 2004 Jul 15; 59(4):943-51. PubMed ID: 15234027 [Abstract] [Full Text] [Related]
15. [Recent topics in chemotherapy for elderly patients with lung cancer]. Okamoto H, Watanabe K. Gan To Kagaku Ryoho; 2000 Jul 15; 27(8):1097-104. PubMed ID: 10945002 [Abstract] [Full Text] [Related]
17. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study. Ettinger DS, Berkey BA, Abrams RA, Fontanesi J, Machtay M, Duncan PJ, Curran WJ, Movsas B, Byhardt RW, Radiation Therapy Oncology Group 9609. J Clin Oncol; 2005 Aug 01; 23(22):4991-8. PubMed ID: 15939930 [Abstract] [Full Text] [Related]
18. The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study. Bonner JA, McGinnis WL, Stella PJ, Marschke RF, Sloan JA, Shaw EG, Mailliard JA, Creagan ET, Ahuja RK, Johnson PA. Cancer; 1998 Mar 15; 82(6):1037-48. PubMed ID: 9506347 [Abstract] [Full Text] [Related]
19. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis. Spiro SG, James LE, Rudd RM, Trask CW, Tobias JS, Snee M, Gilligan D, Murray PA, Ruiz de Elvira MC, O'Donnell KM, Gower NH, Harper PG, Hackshaw AK, London Lung Cancer Group. J Clin Oncol; 2006 Aug 20; 24(24):3823-30. PubMed ID: 16921033 [Abstract] [Full Text] [Related]
20. The evolving role of radiation therapy in the treatment of locally advanced lung cancer. Hazuka MB, Turrisi AT. Semin Oncol; 1993 Apr 20; 20(2):173-84. PubMed ID: 8386856 [Abstract] [Full Text] [Related] Page: [Next] [New Search]